• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PGC-1α 引发神经保护对抗神经退行性疾病的火焰。

PGC-1α sparks the fire of neuroprotection against neurodegenerative disorders.

机构信息

Key Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, Faculty of Life Sciences, Northwest University, 229 Taibai North Road, Xi'an 710069, China; Department of Biomedical Engineering, The Fourth Military Medical University, 169 Changle West Road, Xi'an 710032, China.

Department of Aerospace Medicine, The Fourth Military Medical University, 169 Changle West Road, Xi'an 710032, China.

出版信息

Ageing Res Rev. 2018 Jul;44:8-21. doi: 10.1016/j.arr.2018.03.004. Epub 2018 Mar 23.

DOI:10.1016/j.arr.2018.03.004
PMID:29580918
Abstract

Recently, growing evidence has demonstrated that peroxisome proliferator activated receptor γ (PPARγ) coactivator-1α (PGC-1α) is a superior transcriptional regulator that acts via controlling the expression of anti-oxidant enzymes and uncoupling proteins and inducing mitochondrial biogenesis, which plays a beneficial part in the central nervous system (CNS). Given the significance of PGC-1α, we summarize the current literature on the molecular mechanisms and roles of PGC-1α in the CNS. Thus, in this review, we first briefly introduce the basic characteristics regarding PGC-1α. We then depict some of its important cerebral functions and discuss upstream modulators, partners, and downstream effectors of the PGC-1α signaling pathway. Finally, we highlight recent progress in research on the involvement of PGC-1α in certain major neurodegenerative disorders (NDDs), including Alzheimer's disease, Parkinson's disease, Huntington's disease, and amyotrophic lateral sclerosis. Collectively, the data presented here may be useful for supporting the future potential of PGC-1α as a therapeutic target.

摘要

最近,越来越多的证据表明过氧化物酶体增殖物激活受体γ(PPARγ)共激活因子-1α(PGC-1α)是一种优越的转录调节因子,通过控制抗氧化酶和解偶联蛋白的表达以及诱导线粒体生物发生来发挥作用,这对中枢神经系统(CNS)有益。鉴于 PGC-1α 的重要性,我们总结了目前关于 PGC-1α 在中枢神经系统中的分子机制和作用的文献。因此,在这篇综述中,我们首先简要介绍 PGC-1α 的基本特征。然后,我们描述了它在大脑中的一些重要功能,并讨论了 PGC-1α 信号通路的上游调节剂、伴侣和下游效应物。最后,我们强调了 PGC-1α 参与某些主要神经退行性疾病(NDDs)的研究的最新进展,包括阿尔茨海默病、帕金森病、亨廷顿病和肌萎缩侧索硬化症。总之,这里呈现的数据可能有助于支持 PGC-1α 作为治疗靶点的未来潜力。

相似文献

1
PGC-1α sparks the fire of neuroprotection against neurodegenerative disorders.PGC-1α 引发神经保护对抗神经退行性疾病的火焰。
Ageing Res Rev. 2018 Jul;44:8-21. doi: 10.1016/j.arr.2018.03.004. Epub 2018 Mar 23.
2
Peroxisom proliferator-activated receptor-γ coactivator-1α in neurodegenerative disorders: A promising therapeutic target.过氧化物酶体增殖物激活受体γ共激活因子-1α在神经退行性疾病中的作用:一个有前景的治疗靶点。
Biochem Pharmacol. 2023 Sep;215:115717. doi: 10.1016/j.bcp.2023.115717. Epub 2023 Jul 28.
3
Role of PGC-1α in Mitochondrial Quality Control in Neurodegenerative Diseases.PGC-1α 在神经退行性疾病中线粒体质量控制中的作用。
Neurochem Res. 2019 Sep;44(9):2031-2043. doi: 10.1007/s11064-019-02858-6. Epub 2019 Aug 13.
4
The role of PGC-1α in the pathogenesis of neurodegenerative disorders.PGC-1α 在神经退行性疾病发病机制中的作用。
Curr Drug Targets. 2010 Oct;11(10):1262-9. doi: 10.2174/1389450111007011262.
5
Disruption of peroxisome proliferator-activated receptor γ coactivator (PGC)-1α reverts key features of the neoplastic phenotype of glioma cells.破坏过氧化物酶体增殖物激活受体γ共激活因子(PGC)-1α可逆转神经胶质瘤细胞恶性表型的关键特征。
J Biol Chem. 2019 Mar 1;294(9):3037-3050. doi: 10.1074/jbc.RA118.006993. Epub 2018 Dec 21.
6
PGC-1α overexpression exacerbates β-amyloid and tau deposition in a transgenic mouse model of Alzheimer's disease.过表达 PGC-1α 可加重阿尔茨海默病转基因小鼠模型中的β-淀粉样蛋白和 tau 沉积。
FASEB J. 2014 Apr;28(4):1745-55. doi: 10.1096/fj.13-236331. Epub 2014 Jan 7.
7
Peroxisome Proliferator Activator Receptor Gamma Coactivator-1α Overexpression in Amyotrophic Lateral Sclerosis: A Tale of Two Transgenics.过氧化物酶体增殖物激活受体γ共激活因子-1α在肌萎缩侧索硬化症中的过表达:两种转基因动物的故事。
Biomolecules. 2020 May 13;10(5):760. doi: 10.3390/biom10050760.
8
Curcumin regulates peroxisome proliferator-activated receptor-γ coactivator-1α expression by AMPK pathway in hepatic stellate cells in vitro.姜黄素通过 AMPK 通路调节肝星状细胞中过氧化物酶体增殖物激活受体-γ共激活因子-1α的表达。
Eur J Pharmacol. 2015 Jan 5;746:56-62. doi: 10.1016/j.ejphar.2014.10.055. Epub 2014 Nov 12.
9
PPARγ and PGC-1α as therapeutic targets in Parkinson's.过氧化物酶体增殖物激活受体γ和过氧化物酶体增殖物激活受体γ共激活因子1α作为帕金森病的治疗靶点。
Neurochem Res. 2015 Feb;40(2):308-16. doi: 10.1007/s11064-014-1377-0. Epub 2014 Jul 10.
10
Minutes of PPAR-γ agonism and neuroprotection.过氧化物酶体增殖物激活受体-γ 激动剂和神经保护作用的记录。
Neurochem Int. 2020 Nov;140:104814. doi: 10.1016/j.neuint.2020.104814. Epub 2020 Aug 3.

引用本文的文献

1
Peripheral monocyte transcriptional signatures of inflammation and oxidative stress in Parkinson's disease.帕金森病中炎症和氧化应激的外周单核细胞转录特征
Front Immunol. 2025 Jul 23;16:1571074. doi: 10.3389/fimmu.2025.1571074. eCollection 2025.
2
Intervention strategies for Parkinson's disease: the role of exercise and mitochondria.帕金森病的干预策略:运动与线粒体的作用
Front Aging Neurosci. 2025 May 14;17:1519672. doi: 10.3389/fnagi.2025.1519672. eCollection 2025.
3
Lecithin Alleviates Memory Deficits and Muscle Attenuation in Chinese Older Adults and SAMP8 Mice.
卵磷脂可缓解中国老年人和SAMP8小鼠的记忆缺陷及肌肉萎缩。
Adv Sci (Weinh). 2025 Aug;12(30):e2405222. doi: 10.1002/advs.202405222. Epub 2025 May 9.
4
Therapeutic mechanistic study of novel indole derivatives as SIRTUIN3 modulators in Parkinson's disease with in vitro evaluation.新型吲哚衍生物作为帕金森病中SIRTUIN3调节剂的治疗机制研究及体外评价
Sci Rep. 2025 Apr 30;15(1):15196. doi: 10.1038/s41598-025-99534-3.
5
Decrypting the Possible Mechanistic Role of Fenofibrate in Alzheimer's Disease and Type 2 Diabetes: The Truth and Mystery.解密非诺贝特在阿尔茨海默病和2型糖尿病中可能的机制作用:真相与谜团
J Cell Mol Med. 2025 Mar;29(5):e70378. doi: 10.1111/jcmm.70378.
6
A promising drug repurposing approach for Alzheimer's treatment: Givinostat improves cognitive behavior and pathological features in APP/PS1 mice.一种用于治疗阿尔茨海默病的有前景的药物重新利用方法:吉维诺司他改善APP/PS1小鼠的认知行为和病理特征。
Redox Biol. 2024 Dec;78:103420. doi: 10.1016/j.redox.2024.103420. Epub 2024 Nov 6.
7
Novel PPAR-γ agonists as potential neuroprotective agents against Alzheimer's disease: rational design, synthesis evaluation, PPAR-γ binding assay and transactivation and expression studies.新型PPAR-γ激动剂作为抗阿尔茨海默病的潜在神经保护剂:合理设计、合成评估、PPAR-γ结合测定以及反式激活和表达研究
RSC Adv. 2024 Oct 21;14(45):33247-33266. doi: 10.1039/d4ra06330a. eCollection 2024 Oct 17.
8
SIRT1 Regulates Mitochondrial Damage in N2a Cells Treated with the Prion Protein Fragment 106-126 via PGC-1α-TFAM-Mediated Mitochondrial Biogenesis.SIRT1 通过 PGC-1α-TFAM 介导的线粒体生物发生调节 N2a 细胞中朊病毒蛋白片段 106-126 处理引起的线粒体损伤。
Int J Mol Sci. 2024 Sep 7;25(17):9707. doi: 10.3390/ijms25179707.
9
Baicalein: A potential GLP-1R agonist improves cognitive disorder of diabetes through mitophagy enhancement.黄芩素:一种潜在的胰高血糖素样肽-1受体激动剂,通过增强线粒体自噬改善糖尿病认知障碍。
J Pharm Anal. 2024 Aug;14(8):100968. doi: 10.1016/j.jpha.2024.100968. Epub 2024 Mar 24.
10
Diagnostic value of plasma SIRT1 levels and whole-brain gray matter volume in Parkinson's disease patients with cognitive impairment.血浆 SIRT1 水平和全脑灰质体积对帕金森病伴认知障碍患者的诊断价值。
Neurol Sci. 2024 Jan;45(1):47-54. doi: 10.1007/s10072-023-07071-6. Epub 2023 Sep 18.